Newbridge Financial Services Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-35
| Closed | -$363 | – | 1287 |
|
|
2023
Q3 | $363 | Hold |
35
| – | – | ﹤0.01% | 1219 |
|
|
2023
Q2 | $501 | Hold |
35
| – | – | ﹤0.01% | 1263 |
|
|
2023
Q1 | $250 | Hold |
35
| – | – | ﹤0.01% | 1345 |
|
|
2022
Q4 | $393 | Hold |
35
| – | – | ﹤0.01% | 1367 |
|
|
2022
Q3 | $0 | Hold |
35
| – | – | ﹤0.01% | 1457 |
|
|
2022
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 1482 |
|
|
2022
Q1 | $0 | Hold |
35
| – | – | ﹤0.01% | 1528 |
|
|
2021
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 1351 |
|
|
2021
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 1294 |
|
|
2021
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 1381 |
|
|
2021
Q1 | $1K | Buy |
+35
| New | +$1K | ﹤0.01% | 1308 |
|